Dr. Loren Rourke, a Texas-based board-certified breast cancer surgeon, author and speaker, confirmed research has suggested that glucagon-like peptide-1 medications may be associated with a lower risk of cancer recurrence. Wait times between a cancer diagnosis and the start of treatment grew by nearly two weeks over the past decade in the U.S., according to a recent study published in JAMA Surgery. Researchers from the University of California, Los Angeles and Massachusetts General Hospital analyzed national data from more than two million patients diagnosed between January 2012 and December 2023. The study tracked adults with early to locally advanced stages of six common cancers (breast, colon, lung, pancreatic, stomach and esophageal) who received surgery as part of their initial care. WHERE YOU LIVE COULD SHAPE YOUR RISK OF CANCER MORTALITY, STUD
Aug 17, 2026 → Aug 20, 2026
Dr. Loren Rourke, a Texas-based breast surgical oncologist and author, emphasized that while no lifestyle choice can guarantee cancer prevention, healthy habits can help support the body and reduce certain risk factors. Even as new data…
Read original at Fox News →2 updates from 1 source over 3 days.
Dr. Loren Rourke, a Texas-based breast surgical oncologist and author, emphasized that while no lifestyle choice can guarantee cancer prevention, healthy habits can help support the body and reduce certain risk factors.…
Read original at Fox News →Dr. Loren Rourke, a Texas-based board-certified breast cancer surgeon, author and speaker, confirmed research has suggested that glucagon-like peptide-1 medications may be associated with a lower risk of cancer…
Read original at Fox News →What this story stands on. Tier 0 is a primary record or the subject's own words; higher tiers must be attributed, never stated as bare fact.
Dr. Loren Rourke, a Texas-based breast surgical oncologist and author, emphasized that while no lifestyle choice can guarantee cancer prevention, healthy habits c
View source →Dr. Loren Rourke, a Texas-based board-certified breast cancer surgeon, author and speaker, confirmed research has suggested that glucagon-like peptide-1 medicatio
View source →Tier key: T0 = Primary source · T1 = Wire · T2 = Outlet report · T3 = Commentary
American AI companies’ performance lead over China narrowed sharply in past months to a record low after labs such as DeepSeek gained ground, threatening US tech supremacy,…
President Donald Trump is set to unveil South Korea’s plan to invest some $200 billion in the US, including $54 billion for a long-stalled venture to export natural gas from…
China is reportedly mulling letting ByteDance, Alibaba buy banned Nvidia chips.
The inaugural VivaTech x Bloomberg Awards ceremony, hosted by Bloomberg Television’s Francine Lacqua and Tom Mackenzie, was held on June 18, 2026, at the VivaTech conference in…
The US and Russia have each offered to help each other tackling infectious diseases.
The findings come after warnings from tech leaders that AI placed in the wrong hands could trigger larger threats such as nuclear war or bioweaponry destruction Misusing…
